Identification of 4-quinolone derivatives as inhibitors of reactive oxygen species production from human umbilical vein endothelial cells |
| |
Authors: | Onda Kenichi Narazaki Fumie Ishibashi Naoki Nakanishi Keita Sawada Yuki Imamura Ken-ichiro Momose Kazuhiro Furukawa Shigetada Shimada Yoshiaki Moriguchi Hiroyuki Yuda Masamichi Kayakiri Hiroshi Ohta Mitsuaki |
| |
Affiliation: | Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba, Ibaraki 305-8585, Japan. kenichi.onda@jp.astellas.com |
| |
Abstract: | Oxidative stress is widely recognized as being associated with a number of disorders, including metabolic dysfunction and atherosclerosis. A series of substituted 4-quinolone derivatives were prepared and evaluated as inhibitors of reactive oxygen species (ROS) production from human umbilical vein endothelial cells (HUVECs). One compound in particular, 2-({[4-(3-hydroxy-3-methylbutoxy)pyridin-2-yl]oxy}methyl)-3-methylquinolin-4(1H)-one (25b), inhibited ROS production from HUVECs with an IC(50) of 140 nM. This compound also exhibited low CYP2D6 inhibitory activity, high aqueous solubility, and good in vitro metabolic stability. An in vivo pharmacokinetic study of this compound in SD rats revealed high oral bioavailability and a long plasma half-life. |
| |
Keywords: | Oxidative stress Reactive oxygen species 4-Quinolones HUVECs |
本文献已被 ScienceDirect PubMed 等数据库收录! |